85 reports

## Sample Preparation Requirements for International Customers TABLE ## Estimated new female cases of breast cancer & deaths in US, 2017 TABLE ## North America single-cell genome sequencing market, by product 2014 - 2025 (USD Million) TABLE ## North America single-cell

  • Genome Sequencing
  • Genomics
  • United States
  • Demand
  • Market Size
  • Despite decreasing costs and increasing throughput of genome sequencing, targeted gene sequencing is widely used across the end user segments.
  • Market Drivers

The global microbiome sequencing services market is expected to register a CAGR of 18.0% during the forecast period, 2018 to 2023. North America dominates the market due to a surge in technological advancement in next-generation sequencing (NGS) projects in the region. Huge Investment in Microbiome Research The sequencing of metagenome...

  • Genome Sequencing
  • North America
  • United States
  • World
  • Forecast
  • WHOLE GENOME SEQUENCING
  • COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2017

Global Next-generation Sequencing Market to Register a CAGR of 19.2% from 2018 to 2024 The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing...

  • Genome Sequencing
  • North America
  • United States
  • Forecast
  • Illumina, Inc.
  • GENOME SEQUENCING
  • GLOBAL GENOME SEQUENCING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

In our study, we have segmented the next generation sequencing market by product, service, application and end-users.The products considered in the study are platform, services, and consumables. The platform segment is further segmented as Hiseq, Miseq, Solid, ION Torrent, Pacbio Rs II & Sequel Systems.The sub-segment of services is...

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.
  • 7.7 WHOLE-GENOME SEQUENCING
  • HUMAN WHOLE-GENOME SEQUENCING COST ESTIMATED BY THE NATIONAL

“Global next-generation sequencing (NGS) services market projected to grow at a CAGR of 21.0%” The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 million by 2022 from USD 1,059.2 million in 2017; growing at a CAGR of 21.0% during the forecast period. Factors such as declining price of sequencing,...

  • Genome Sequencing
  • North America
  • United States
  • World
  • QIAGEN N.V.
  • Whole Genome Sequencing
  • Whole Genome Sequencing

The global microbiome sequencing services market is poised to reach USD 1424.7 million by 2021 from USD 538.0 million in 2016, at a CAGR of 21.5% from 2016 to 2021. The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving...

  • Genome Sequencing
  • Genomics
  • World
  • Market Size
  • Zymo Research Corporation
  • JUL 13, 2017: WORLD-LEADING CANCER RESEARCHERS FIRST IN UK TO RECEIVE NOVASEQ - THE LATEST GENOME SEQUENCING TECHNOLOGY
  • JUL 13, 2017: WORLD-LEADING CANCER RESEARCHERS FIRST IN UK TO RECEIVE NOVASEQ - THE LATEST GENOME SEQUENCING TECHNOLOGY

Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology.The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents;...

  • Genome Sequencing
  • Molecular Diagnostic
  • United States
  • Company
  • Illumina, Inc.
  • Global Next Generation Sequencing Services Market in Genome Sequencing, 2015 -
  • Global Next Generation Sequencing Services Market Share, by Key Players 2016 & 2021

According to the new report “Global Next Generation Sequencing Market Assessment & Forecast: 2017 - 2021” by SA-Business Research & Consulting Group, Illumina leads the market with more than 75% market share. The global next generation sequencing market was valued at US$ 3,509.6 Million in 2016 and is expected to reach US$ 7,527.0 Million...

  • Genome Sequencing
  • World
  • Illumina, Inc.
  • Oxford Nanopore Technologies Limited
  • QIAGEN N.V.
  • 5.1.1.1 WHOLE GENOME SEQUENCING
  • Next-generation Sequencing Market: Revenue in USD million, by Sequencing Type,

Next Generation Sequencing (NGS) Market The Global Next Generation Sequencing Market is expected to reach USD XX million by 2022 from USD XX million in 2016, at a CAGR of XX%. Next generation sequencing, also known as high-throughput sequencing, is a DNA sequencing technology that has revolutionized genomic research. Due to its ability...

  • Genome Sequencing
  • North America
  • United States
  • World
  • Roche Group

Genome sequencing/ mapping

  • DNA Sequencing
  • Genome Sequencing
  • Genomics
  • World

Microbiome Sequencing Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022 ##.

  • Genome Sequencing
  • Genomics
  • World
  • Market Shares
  • 5.5 WHOLE GENOME SEQUENCING
  • WHOLE GENOME SEQUENCING MARKET REVENUE, BY

A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was...

  • Genome Sequencing
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • 12.7.4.1 Product/Service Launches and Approvals
  • 12.12 MACROGEN, INC.

The global NGS-based RNA-seq market is projected to reach USD 2.65 billion by 2022 from USD 1.05 billion in 2017, at a CAGR of 20.2%. Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid...

  • Genome Sequencing
  • North America
  • United States
  • World
  • Illumina, Inc.
  • Vendor classification
  • Identifying factors impacting market growth

About Prenatal DNA Sequencing Prenatal DNA sequencing is the method of DNA sequencing where DNA isolated from the blood of pregnant women to reveal the full genetic code of a fetus. It is useful in detecting disorders such as Down syndrome, cystic fibrosis, thalassemia, and cancer. Technavio’s analysts forecast...

  • Genome Sequencing
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Natera, Inc.
  • DURING THE FORECAST PERIOD
  • GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION)

The global gene panels market projected to grow at a CAGR of 19.2%. The global gene panels market is expected to reach USD 2.95 billion by 2023 from USD 1.22 billion in 2018, at a CAGR of 19.2%. This market is experiencing significant growth due increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic...

  • Genome Sequencing
  • North America
  • United States
  • World
  • Thermo Fisher Scientific, Inc.
  • Sep 04, 2017: Macrogen Established Its Branch in Spain, Strengthening Localization Service in Europe
  • Sep 04, 2017: Macrogen Established Its Branch in Spain, Strengthening Localization Service in Europe

Macrogen Inc (038290) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Genome Sequencing
  • Healthcare
  • World
  • Company Financials
  • Macrogen, Inc.
  • Jul 03, 2017: Human Longevity Researchers Develop New Algorithm to Rapidly and Accurately Predict HLA Types Using Illumina Next Generation Sequencing Technology
  • ASSET PURCHASE

Summary Human Longevity Inc (HLI) is a genomics-based technology company that develops sequenced genomes and phenotypic database.The company’s discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and companion diagnostics. It...

  • Genome Sequencing
  • Healthcare
  • Therapy
  • United States
  • Company
  • Indication
  • ILLUMINA INC PIPELINE PRODUCTS AND ONGOING CLINICAL TRIALS OVERVIEW

Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology.The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents;...

  • Genome Sequencing
  • United States
  • Company
  • Company Financials
  • Illumina, Inc.

The TOPMed program colects whole-genome sequencing and other -omics data.

  • Genome Sequencing
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • April 2015
  • HISEQ X TEN & HISEQ X FIVE PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic...

  • Genome Sequencing
  • North America
  • United States
  • Market Size
  • Illumina, Inc.
  • 7.1 BY TECHNOLOGY
  • 5.1 BY TECHNOLOGY

In March 2014, Human Longevity Inc. announced that it would build the world' s largest human genome sequencing center, with the capacity of sequencing up to ##, ## human genomes per year.

  • Genome Sequencing
  • North America
  • United States
  • World
  • QIAGEN N.V.
  • 6.6 BIOINFORMATICS TOOLS
  • GLOBAL BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)

In addition, sequencing the human genome requires massive computational and storage capabilities.

  • Genome Sequencing
  • North America
  • United States
  • World
  • Thermo Fisher Scientific, Inc.
  • HAMILTON ROBOTICS PARTNERS WITH ILLUMINA
  • This agreement enables Analytik Jena and Illumina to provide solutions for ultra-high throughput genotyping.

United States Genetic Testing Market Outlook to 2024 Summary GlobalData’s new report, United States Genetic Testing Market Outlook to 2024, provides key market data on the United States Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired...

  • Diagnostics
  • Genetic
  • Genome Sequencing
  • Hospital
  • Thermo Fisher Scientific, Inc.
  • TAKARA BIO ACQUIRES RUBICON GENOMICS FOR USD75 MILLION
  • VENTURE FINANCING

The technology is currently available for sequencing on Illumina HiSeq, MiSeq and Genome Analyzer instruments.

  • Genome Sequencing
  • Genomics
  • United States
  • Company
  • Takara Bio Inc.

The company' s research software, HLA Explore analyzes data from any sequencing technology and determines HLA genotypes from Whole Exome/ Genome Sequencing experiments.

  • Genome Sequencing
  • Prosthesis
  • North America
  • United States
  • Market Size
  • Feb 12, 2018: New GUINNESS WORLD RECORDS Title Set for Fastest Genetic Diagnosis
  • Product Category: Instruments

Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Genome Sequencing
  • Molecular Diagnostic
  • United States
  • Company Financials
  • Illumina, Inc.
  • 9.2 ILLUMINA INC

NextSeq series MiSeq series Description HiSeq X five series The HiSeq X Five System enables fast and affordable human whole-genome sequencing on a massive scale.

  • Genome Sequencing
  • North America
  • United States
  • World
  • Market Size
  • JUL 02, 2018: GRANDOMICS BECOMES THE FIRST CERTIFIED PROMETHION SERVICE PROVIDER IN CHINA
  • VENTURE FINANCING

Summary Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., develops disruptive, electronic, and single-molecule sensing system. The company’s products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of...

  • Genome Sequencing
  • Medical Equipment
  • Nanopore
  • United Kingdom
  • Oxford Nanopore Technologies Limited
  • ILLUMINA, INC.: CORPORATE GOVERNANCE
  • ILLUMINA, INC.: RECENT DEVELOPMENTS

Illumina, Inc. - Strategy, SWOT and Corporate Finance Report Summary Illumina, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate...

  • Genome Sequencing
  • Genomics
  • United States
  • Company
  • Illumina, Inc.

Based on technology the market is categorized into single molecule real time sequencing, sequencing by synthesis, sequencing by ligation, pyrosequencing, ion semiconductor sequencing and other technologies.

  • Genome Sequencing
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • World
  • Forecast